New hope for advanced cervical cancer? trial tests extra chemo after radiation
NCT ID NCT04016142
First seen Mar 31, 2026 · Last updated May 23, 2026 · Updated 10 times
Summary
This study looked at whether adding a specific chemotherapy combination (carboplatin and paclitaxel) after standard chemoradiation could help people with advanced cervical cancer that has spread to lymph nodes in the abdomen. The trial planned to enroll 21 participants but was stopped early. The goal was to see if the extra chemo could delay cancer growth or improve survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Hospitalier de Lens
Lens, France
-
Centre Léonard de Vinci
Dechy, France, France
-
Centre Marie Curie
Arras, France, France
-
Centre Oscar Lambret
Lille, France, France
-
Centre Pierre Curie
Beuvry, France, France
-
Clinique des dentellières
Valenciennes, France, France
Conditions
Explore the condition pages connected to this study.